Can we see what is invisible? The role of MRI in the evaluation and management of patients with pathological nipple discharge
Sign Up to like & getrecommendations! Published in 2019 at "Breast Cancer Research and Treatment"
DOI: 10.1007/s10549-019-05321-w
Abstract: The aim of this study was to determine the ability of MRI to identify and assess the extent of disease in patients with pathological nipple discharge (PND) with an occult malignancy not evident on standard… read more here.
Keywords: nipple discharge; patients pathological; mri; pathological nipple ... See more keywords
Effects of oral immunonutritional supplement on 3-year disease-free survival in gastric cancer patients with pathological stage III after total gastrectomy (CRUCIAL): study protocol of a multicentre, randomised clinical trial
Sign Up to like & getrecommendations! Published in 2023 at "BMJ Open"
DOI: 10.1136/bmjopen-2022-067990
Abstract: Introduction The nutritional status of patients with gastric cancer (GC) after total gastrectomy continues to deteriorate and lasts a long time after discharge, which is an independent risk factor for mortality. Recent guidelines have recommended… read more here.
Keywords: year; patients pathological; gastrectomy; pathological stage ... See more keywords
A Prediction Rule for Overall Survival in Non-Small-Cell Lung Cancer Patients with a Pathological Tumor Size Less Than 30 mm
Sign Up to like & getrecommendations! Published in 2019 at "Disease Markers"
DOI: 10.1155/2019/8435893
Abstract: We sought to develop and validate a clinical nomogram model for predicting overall survival (OS) in non-small-cell lung cancer (NSCLC) patients with resected tumors that were 30 mm or smaller, using clinical data and molecular marker… read more here.
Keywords: pathological tumor; tumor size; patients pathological; size less ... See more keywords
Role of adjuvant chemotherapy in patients with pathological stage I NSCLC with high-risk features.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.9022
Abstract: 9022Background: Lobectomy is the current standard of care for patients with stage I non-small cell lung cancer (NSCLC). There is a lack of prospective data on the benefit of adjuvant chemotherapy (... read more here.
Keywords: adjuvant chemotherapy; chemotherapy patients; patients pathological; role adjuvant ... See more keywords